Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents
- PMID: 17697875
- DOI: 10.1016/j.metabol.2007.05.004
Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents
Abstract
Visceral fat is highly correlated with metabolic syndrome in obese adolescents. The aims of this study were to determine the prevalence of metabolic syndrome and to assess the effect of a long-term (1 year) intervention with multidisciplinary therapy in predicting metabolic syndrome among obese adolescents, as well as to compare short- with long-term therapy. Eighty-three postpuberty obese adolescents were recruited, including 37 boys (body mass index [BMI], 36.19 +/- 3.85 kg/m(2)) and 46 girls (BMI, 35.73 +/- 4.42 kg/m(2)). Body composition was measured by plethysmography using the BOD POD body composition system (version 1.69, Life Measurement Instruments, Concord, CA), and visceral fat was analyzed by ultrasound. Metabolic syndrome was determined according to the World Health Organization criteria. Patients were assigned to a weight loss multidisciplinary intervention consisting of nutritional, exercise, psychological, and clinical therapy. At the beginning of therapy, we found that 27.16% of the obese adolescents presented metabolic syndrome, whereas only 8.3% did so after intervention. Indeed, in boys, BMI (36.19 +/- 3.85 to 32.06 +/- 5.85 kg/m(2)), visceral fat (4.88 +/- 1.35 to 3.63 +/- 1.71 cm), homeostasis model assessment of insulin resistance (4.77 +/- 3.41 to 3.18 +/- 2.33), and percentage of body fat (38.24% +/- 6.54% to 30.02% +/- 13.43%) presented a statistically significant reduction; and their fat-free mass percentage increased (62.14% +/- 5.78% to 69.17% +/- 12.37%). In girls, after long-term therapy, BMI (35.73 +/- 4.42 to 33.62 +/- 3.78 kg/m(2)), visceral fat (3.70 +/- 1.40 to 2.75 +/- 1.01 cm), and percentage of body fat (46.10% +/- 5.66% to 39.91% +/- 5.59%) showed a statistically significant reduction; and their fat-free mass increased (53.61% +/- 5.65% to 59.82% +/- 5.78%). In conclusion, long-term multidisciplinary therapy was effective in promoting beneficial changes in some predictors and decreasing the prevalence of metabolic syndrome in obese adolescents.
Similar articles
-
Long-term multidisciplinary therapy decreases predictors and prevalence of metabolic syndrome in obese adolescents.Nutr Metab Cardiovasc Dis. 2007 Jul;17(6):e11-3. doi: 10.1016/j.numecd.2006.11.003. Epub 2007 May 16. Nutr Metab Cardiovasc Dis. 2007. PMID: 17509840 Clinical Trial. No abstract available.
-
Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.J Am Acad Nurse Pract. 2007 Jul;19(7):368-77. doi: 10.1111/j.1745-7599.2007.00236.x. J Am Acad Nurse Pract. 2007. PMID: 17680902
-
Ectopic fat deposition and the metabolic syndrome in obese children and adolescents.Horm Res. 2009 Jan;71 Suppl 1:2-7. doi: 10.1159/000178028. Epub 2009 Jan 21. Horm Res. 2009. PMID: 19153496
-
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20. Arterioscler Thromb Vasc Biol. 2008. PMID: 18356555 Review.
-
Physical activity as the main therapeutic tool for metabolic syndrome in childhood.Int J Obes (Lond). 2011 Jan;35(1):16-28. doi: 10.1038/ijo.2010.255. Epub 2010 Dec 7. Int J Obes (Lond). 2011. PMID: 21139560 Review.
Cited by
-
Dyslipidemia Diagnosis and Treatment: Risk Stratification in Children and Adolescents.J Nutr Metab. 2022 Feb 21;2022:4782344. doi: 10.1155/2022/4782344. eCollection 2022. J Nutr Metab. 2022. PMID: 35237450 Free PMC article. Review.
-
Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment.Diabetol Metab Syndr. 2010 Aug 18;2:55. doi: 10.1186/1758-5996-2-55. Diabetol Metab Syndr. 2010. PMID: 20718958 Free PMC article.
-
Assessing and Managing the Metabolic Syndrome in Children and Adolescents.Nutrients. 2019 Aug 2;11(8):1788. doi: 10.3390/nu11081788. Nutrients. 2019. PMID: 31382417 Free PMC article. Review.
-
Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance.Int J Endocrinol. 2013;2013:541032. doi: 10.1155/2013/541032. Epub 2013 Oct 27. Int J Endocrinol. 2013. PMID: 24285955 Free PMC article.
-
Metabolic syndrome severity and lifestyle factors among adolescents.Minerva Pediatr. 2018 Oct;70(5):467-475. doi: 10.23736/S0026-4946.18.05290-8. Epub 2018 Jul 2. Minerva Pediatr. 2018. PMID: 29968453 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical